HOME >> MEDICINE >> NEWS
Mouse shows how Rituximab removes human B cells

The monoclonal antibody Rituximab has been approved for the treatment of non-Hodgkin's lymphoma since 1997, but how Rituximab disposes of the cancerous (and normal) B cells is unknown. Research in a new mouse model reported in The Journal of Experimental Medicine suggests that the drug works by triggering the removal of B lymphocytes by scavenger cells.

Antibodies like Rituximab can remove cells in a variety of ways, including killing cells directly, inducing cell suicide, or triggering killing by other immune cells and molecules. Rituximab binds to CD20, a protein found on the surface of all B lymphocytes. In humans it is difficult to analyze how this leads to the elimination of B lymphocytes as only small numbers of cells can be sampled from the blood.

To mimic the clinical situation, Thomas Tedder and colleagues treated mice with a panel of antibodies specific for mouse CD20 (Rituximab is an antibody that binds to human but not mouse B cells). The antibodies that were effective in removing B cells did so by allowing B cell recognition by specialized 'scavenger' immune cells known as macrophages, which carry antibody receptors on their surface.

Less than half of patients with lymphoma respond to anti-CD20 therapy, so drugs that increase the number of macrophages or levels of antibody receptors might improve the response to Rituximab.

The new insight into how CD20 antibodies remove B cells should allow the design of better therapies not only for lymphoma, but also autoimmune diseases caused by rogue self-reactive B cells (as in rheumatoid arthritis), in which CD20 antibody trials are already underway.


'"/>

Contact: Nickey Henry
henryn@rockefeller.edu
212-327-8366
Journal of Experimental Medicine
21-Jun-2004


Page: 1

Related medicine news :

1. Mouse model reveals potential way to reduce cardiac deaths in kidney patients
2. Mouse gene shows new mechanism behind cardiac infarction in man
3. Mouse model gives insight to human hair loss
4. Mouse study: Signal overload in Alzheimer brains
5. Mouse study could aid vaccine designers
6. Mouse model mimics real-world plague infection
7. Mouse antibodies thwart SARS virus
8. Mouse model of neuromuscular disease identifies key player in motor neuron death
9. Mouse study gives new view of anthrax toxin
10. Mouse studies reveal immune mechanism involved in bone loss caused by estrogen deficiency
11. Mouse provides clues about chronic pain

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... ... 2020 , ... International Dark-Sky Association (IDA) recently bestowed the ... This advanced LED wireless dimming controller, along with the previously IDA approved Dimulator, ... against light pollution. Leo Smith, the Northeast Regional Director for IDA says “We ...
(Date:9/1/2020)... (PRWEB) , ... September 01, 2020 , ... ... a new practice in Glendale. While the office will be the first ... breast augmentation, tummy tucks, buttock augmentation (Brazilian butt lift), as well as rhinoplasty, ...
(Date:9/1/2020)... ... September 01, 2020 , ... Feeding Matters , the first organization in ... Disorder (PFD), is pleased to announce that the U.S. Centers for Disease Control and ... in the next edition of the U.S. International Classification of Diseases (ICD ) ...
(Date:9/1/2020)... ... September 01, 2020 , ... Dr. Kiran ... in aesthetic surgery of the face, breast, and body. In 2018, she founded ... boutique plastic surgery and aesthetic practice in Southwest Florida. Dr. Gill and her ...
(Date:8/31/2020)... , ... August 31, 2020 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – today announced the 10th Anniversary of Blood Cancer Awareness Month (BCAM) and ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... ... September 03, 2020 , ... In response ... return to schools and classrooms across the United States, IntraLogic Solutions , ... product line. TEMPE is a non-contact, wall-mounted scanning thermometer that rapidly checks body ...
(Date:9/1/2020)... ... September 01, 2020 , ... Mara C. Weinstein Velez, ... at the University of Rochester Medical Center, in Upstate New York. She completed ... with clinical faculty from the Harvard and Yale Departments of Dermatology and is ...
(Date:8/31/2020)... ... August 31, 2020 , ... Welltech1, the first Israeli ... have invested $400,000 in PopBase, one of two start-ups that beat 152 companies ... Institute (GWI). , The competition was part of the GWI’s The Wellness ...
Breaking Medicine Technology:
Cached News: